| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sandra G Resnick, Robert A Rosenheck, Jose M Canive, Cyril De Souza, T Scott Stroup, Joseph McEvoy, Sonia Davis, Richard S E Keefe, Marvin Swartz, Jeffrey Lieberma. Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia. The journal of behavioral health services & research. vol 35. issue 2. 2008-06-17. PMID:18246429. |
a randomized controlled trial (catie) examined medication assignment and both employment outcomes and participation in psychosocial rehabilitation (psr) among 1,121 individuals with a diagnosis of schizophrenia randomized to sgas (olanzapine, quetiapine, risperidone, ziprasidone) or one fga (perphenazine). |
2008-06-17 |
2023-08-12 |
Not clear |
| Massimo C Mauri, Donatella Moliterno, Matteo Rossattini, Alessandro Colasant. Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs. Schizophrenia research. vol 99. issue 1-3. 2008-05-27. PMID:18055177. |
the data were drawn from a retrospective, naturalistic, observational study in which 222 subjects diagnosed as being affected by schizophrenia during a re-exacerbation phase received 6 weeks of monotherapy with fluphenazine decanoate, haloperidol decanoate, haloperidol, clozapine, olanzapine, quetiapine, risperidone or l-sulpiride. |
2008-05-27 |
2023-08-12 |
human |
| Istvan Bitter, Tamas Treuer, Yulia Dyachkova, Ferenc Martenyi, Margaret McBride, Gabor S Ungvar. Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 18. issue 3. 2008-05-22. PMID:17884390. |
this report describes antipsychotic prescription patterns for outpatients with schizophrenia prescribed olanzapine (n=3,222), clozapine (n=236), risperidone (n=1,117), quetiapine (n=189) or haloperidol (n=256) monotherapy at study entry and treated in a naturalistic, clinical practice setting over 24 months. |
2008-05-22 |
2023-08-12 |
Not clear |
| Lesley J Scott, Sohita Dhillo. Spotlight on risperidone in irritability associated with autistic disorder in children and adolescents. CNS drugs. vol 22. issue 3. 2008-05-19. PMID:18278980. |
the clinical efficacy of oral risperidone in the treatment of bipolar mania and schizophrenia in adult patients is well established. |
2008-05-19 |
2023-08-12 |
Not clear |
| Lesley J Scott, Sohita Dhillo. Spotlight on risperidone in irritability associated with autistic disorder in children and adolescents. CNS drugs. vol 22. issue 3. 2008-05-19. PMID:18278980. |
in the us, risperidone is also approved for the treatment of irritability associated with autistic disorder in children and adolescents aged 5-16 years, for the treatment of schizophrenia in adolescents aged 13-17 years and, as monotherapy, for the short-term treatment of acute manic and mixed episodes associated with bipolar i disorder in children and adolescents aged 10-17 years. |
2008-05-19 |
2023-08-12 |
Not clear |
| Jing-li Liu, Li Ma, Yong Wan. [Clinical observation on effect of modified Daotan Decoction combined with small dose risperidone in treating chronic schizophrenia]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. vol 27. issue 3. 2008-05-09. PMID:17432677. |
[clinical observation on effect of modified daotan decoction combined with small dose risperidone in treating chronic schizophrenia]. |
2008-05-09 |
2023-08-12 |
Not clear |
| Jing-li Liu, Li Ma, Yong Wan. [Clinical observation on effect of modified Daotan Decoction combined with small dose risperidone in treating chronic schizophrenia]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. vol 27. issue 3. 2008-05-09. PMID:17432677. |
to evaluate the clinical efficacy of modified daotan decoction (dd) combining low dosage of risperidone in treating chronic schizophrenia patients of phlegm-dampness blockage type, and compare with patients treated with risperidone alone. |
2008-05-09 |
2023-08-12 |
Not clear |
| Aiping Zhang, Qinghe Xing, Lei Wang, Jing Du, Lan Yu, Zhiguang Lin, Xingwang Li, Guoyin Feng, Lin H. Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study. Pharmacogenomics. vol 8. issue 10. 2008-04-25. PMID:17979508. |
dopamine transporter polymorphisms and risperidone response in chinese schizophrenia patients: an association study. |
2008-04-25 |
2023-08-12 |
Not clear |
| Aiping Zhang, Qinghe Xing, Lei Wang, Jing Du, Lan Yu, Zhiguang Lin, Xingwang Li, Guoyin Feng, Lin H. Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study. Pharmacogenomics. vol 8. issue 10. 2008-04-25. PMID:17979508. |
in this study, we investigated the pharmacogenetic correlates of slc6a3 and response to risperidone treatment in 130 chinese schizophrenia patients. |
2008-04-25 |
2023-08-12 |
Not clear |
| Xing-shi Chen, Ming-dao Zhang, Fei-ying Lou, Hong-xing Wang, Ji-jun Wang, Jian-hua Liang, Chong Chen, Xin-wei Chen, Li Liu, Cun-you Gao, Ping Liu, Xiao-wei Li. [Effects of risperidone on polysomnography in patients with first-episode schizophrenia]. Zhonghua yi xue za zhi. vol 86. issue 35. 2008-04-24. PMID:17156674. |
[effects of risperidone on polysomnography in patients with first-episode schizophrenia]. |
2008-04-24 |
2023-08-12 |
Not clear |
| Xing-shi Chen, Ming-dao Zhang, Fei-ying Lou, Hong-xing Wang, Ji-jun Wang, Jian-hua Liang, Chong Chen, Xin-wei Chen, Li Liu, Cun-you Gao, Ping Liu, Xiao-wei Li. [Effects of risperidone on polysomnography in patients with first-episode schizophrenia]. Zhonghua yi xue za zhi. vol 86. issue 35. 2008-04-24. PMID:17156674. |
to investigate the effects of risperidone on the polysomnography (psg) in the patients with first-episode schizophrenia. |
2008-04-24 |
2023-08-12 |
Not clear |
| Ana Paula Werneck de Castro, Helio Elki. Rehospitalization rates of patients with schizophrenia discharged on haloperidol, risperidone or clozapine. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). vol 29. issue 3. 2008-04-24. PMID:17891257. |
rehospitalization rates of patients with schizophrenia discharged on haloperidol, risperidone or clozapine. |
2008-04-24 |
2023-08-12 |
Not clear |
| Donald C Goff, J Steven Lamberti, Andrew C Leon, Michael F Green, Alexander L Miller, Jayendra Patel, Theo Manschreck, Oliver Freudenreich, Steven A Johnso. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 3. 2008-04-23. PMID:17487227. |
stable schizophrenia patients treated with clozapine (n=52), olanzapine (n=40), or risperidone (n=13) were randomly assigned to add-on treatment with cx516 900 mg three times daily or placebo for 4 weeks. |
2008-04-23 |
2023-08-12 |
human |
| Donald C Goff, J Steven Lamberti, Andrew C Leon, Michael F Green, Alexander L Miller, Jayendra Patel, Theo Manschreck, Oliver Freudenreich, Steven A Johnso. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 3. 2008-04-23. PMID:17487227. |
cx516 was not effective for cognition or for symptoms of schizophrenia when added to clozapine, olanzapine, or risperidone. |
2008-04-23 |
2023-08-12 |
human |
| Emilio Sacchetti, Paolo Valsecchi, Giovanni Parrinell. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial. Schizophrenia research. vol 98. issue 1-3. 2008-03-31. PMID:17933497. |
a randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the querisola trial. |
2008-03-31 |
2023-08-12 |
Not clear |
| Emilio Sacchetti, Paolo Valsecchi, Giovanni Parrinell. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial. Schizophrenia research. vol 98. issue 1-3. 2008-03-31. PMID:17933497. |
this was a randomized, flexible-dose, rater-blind, parallel-group, quasi-naturalistic trial comparing the efficacy, safety, and tolerability of quetiapine, risperidone, and olanzapine in patients with schizophrenia hospitalized for severe psychotic symptoms. |
2008-03-31 |
2023-08-12 |
Not clear |
| Hsien-Yuan Lane, Yi-Ching Liu, Chieh-Liang Huang, Yue-Cune Chang, Po-Lun Wu, Chiung-Hsien Huang, Guochuan E Tsa. RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia. Journal of clinical psychopharmacology. vol 28. issue 1. 2008-03-27. PMID:18204343. |
rgs4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia. |
2008-03-27 |
2023-08-12 |
Not clear |
| Hsien-Yuan Lane, Yi-Ching Liu, Chieh-Liang Huang, Yue-Cune Chang, Po-Lun Wu, Chiung-Hsien Huang, Guochuan E Tsa. RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia. Journal of clinical psychopharmacology. vol 28. issue 1. 2008-03-27. PMID:18204343. |
this study aims to investigate the association of 4 rgs4 polymorphisms (single nucleotide polymorphisms [snps] 1, 4, 7, and 18), implicated in previous studies, with baseline symptoms and treatment response to risperidone in patients with schizophrenia. |
2008-03-27 |
2023-08-12 |
Not clear |
| Nael Kilzieh, Jeffrey A Todd-Stenberg, Annette Kennedy, Amanda E Wood, Andre M Tap. Time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient setting. Journal of clinical psychopharmacology. vol 28. issue 1. 2008-03-27. PMID:18204345. |
time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient setting. |
2008-03-27 |
2023-08-12 |
Not clear |
| Nael Kilzieh, Jeffrey A Todd-Stenberg, Annette Kennedy, Amanda E Wood, Andre M Tap. Time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient setting. Journal of clinical psychopharmacology. vol 28. issue 1. 2008-03-27. PMID:18204345. |
we examined the effectiveness of olanzapine and risperidone in schizophrenia in a naturalistic setting. |
2008-03-27 |
2023-08-12 |
Not clear |